Paper25749385
G9a is essential for EMT-mediated metastasis and maintenance of cancer stem cell-like characters in head and neck squamous cell carcinoma.
Liu S and 19 others. Oncotarget, 2015. Cited by 106 papers, by iCite.
Cite this record
ConductScience Library. G9a is essential for EMT-mediated metastasis and maintenance of cancer stem cell-like characters in head and neck squamous cell carcinoma. Papers, record 25749385. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/25749385
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- G9a is essential for EMT-mediated metastasis and maintenance of cancer stem cell-like characters in head and neck squamous cell carcinoma.
- PubMed
Topics24
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Carcinoma, Squamous Cell | Major topic |
| Epithelial-Mesenchymal Transition | Major topic |
| Gene Expression Regulation, Neoplastic | Major topic |
| Head and Neck Neoplasms | Major topic |
| Histocompatibility Antigens | Major topic |
| Histone-Lysine N-Methyltransferase | Major topic |
| Neoplastic Stem Cells | Major topic |
| Antigens, CD | |
| Cadherins | |
| Cell Movement | |
| Flow Cytometry | |
| Histones | |
| Humans | |
| Lymphatic Metastasis | |
| Methylation | |
| Neoplasm Metastasis | |
| Neoplasm Recurrence, Local | |
| Neoplasm Transplantation | |
| Prognosis | |
| Squamous Cell Carcinoma of Head and Neck | |
| Stem Cells | |
| Transforming Growth Factor beta | |
| Treatment Outcome | |
| Wound Healing |
Source PubMed
References63
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 24315373 | The histone H3 methyltransferase G9A epigenetically activates the serine-glycine synthesis pathway to sustain cancer cell survival and proliferation. | Cell Metab | 2013 | https://conductscience.org/library/papers/24315373 | PubMed |
| 2 | 16982742 | Hypoxic stress induces dimethylated histone H3 lysine 9 through histone methyltransferase G9a in mammalian cells. | Cancer Res | 2006 | https://conductscience.org/library/papers/16982742 | PubMed |
| 3 | 17909537 | Histone lysine demethylases: emerging roles in development, physiology and disease. | Nat Rev Genet | 2007 | https://conductscience.org/library/papers/17909537 | PubMed |
| 4 | 17978854 | Pre-EMTing metastasis? Recapitulation of morphogenetic processes in cancer. | Clin Exp Metastasis | 2007 | https://conductscience.org/library/papers/17978854 | PubMed |
| 5 | 18446223 | Downregulation of histone H3 lysine 9 methyltransferase G9a induces centrosome disruption and chromosome instability in cancer cells. | PLoS One | 2008 | https://conductscience.org/library/papers/18446223 | PubMed |
| 6 | 18485877 | The epithelial-mesenchymal transition generates cells with properties of stem cells. | Cell | 2008 | https://conductscience.org/library/papers/18485877 | PubMed |
| 7 | 18784658 | Cancer stem cells in solid tumours: accumulating evidence and unresolved questions. | Nat Rev Cancer | 2008 | https://conductscience.org/library/papers/18784658 | PubMed |
| 8 | 19118778 | Changes in immunoexpression of E-cadherin and beta-catenin in oral squamous cell carcinoma with and without nodal metastasis. | Ann Diagn Pathol | 2009 | https://conductscience.org/library/papers/19118778 | PubMed |
| 9 | 19276366 | Immune-induced epithelial to mesenchymal transition in vivo generates breast cancer stem cells. | Cancer Res | 2009 | https://conductscience.org/library/papers/19276366 | PubMed |
| 10 | 19411070 | Stabilization of snail by NF-kappaB is required for inflammation-induced cell migration and invasion. | Cancer Cell | 2009 | https://conductscience.org/library/papers/19411070 | PubMed |
| 11 | 19487818 | The basics of epithelial-mesenchymal transition. | J Clin Invest | 2009 | https://conductscience.org/library/papers/19487818 | PubMed |
| 12 | 19544473 | Snail and slug mediate radioresistance and chemoresistance by antagonizing p53-mediated apoptosis and acquiring a stem-like phenotype in ovarian cancer cells. | Stem Cells | 2009 | https://conductscience.org/library/papers/19544473 | PubMed |
| 13 | 22389001 | Recruitment of coregulator G9a by Runx2 for selective enhancement or suppression of transcription. | J Cell Biochem | 2012 | https://conductscience.org/library/papers/22389001 | PubMed |
| 14 | 22630087 | TGF-β in epithelial to mesenchymal transition and metastasis of liver carcinoma. | Curr Pharm Des | 2012 | https://conductscience.org/library/papers/22630087 | PubMed |
| 15 | 23087213 | G9a mediates Sharp-1-dependent inhibition of skeletal muscle differentiation. | Mol Biol Cell | 2012 | https://conductscience.org/library/papers/23087213 | PubMed |
| 16 | 23257913 | G9a, a multipotent regulator of gene expression. | Epigenetics | 2013 | https://conductscience.org/library/papers/23257913 | PubMed |
| 17 | 23188671 | Downregulation of miR-153 contributes to epithelial-mesenchymal transition and tumor metastasis in human epithelial cancer. | Carcinogenesis | 2013 | https://conductscience.org/library/papers/23188671 | PubMed |
| 18 | 24402192 | TWIST1 and SNAI1 as markers of poor prognosis in human colorectal cancer are associated with the expression of ALDH1 and TGF-β1. | Oncol Rep | 2014 | https://conductscience.org/library/papers/24402192 | PubMed |
| 19 | 24532712 | The methyltransferase G9a regulates HoxA9-dependent transcription in AML. | Genes Dev | 2014 | https://conductscience.org/library/papers/24532712 | PubMed |
| 20 | 23651229 | Repression of G protein-coupled receptor family C group 5 member A is associated with pathologic differentiation grade of oral squamous cell carcinoma. | J Oral Pathol Med | 2013 | https://conductscience.org/library/papers/23651229 | PubMed |
Cited by85
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 106 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42449712 | Overcoming Therapeutic Resistance in Head and Neck Squamous Cell Carcinoma (HNSCC): The Role of Histone Methyltransferase and Demethylase Inhibitors. | Cancers (Basel) | 2026 | https://conductscience.org/library/papers/42449712 | PubMed |
| 42426154 | The effect of Punicalagin on tongue carcinoma cells viability and angiogenesis by regulating TGF-β signalling pathway: an in vitro study. | Sci Rep | 2026 | https://conductscience.org/library/papers/42426154 | PubMed |
| 41897283 | Targeting G9a Exerts Pleiotropic Suppression in Triple-Negative Breast Cancer Cells: Cooperatively Inducing Pyroptosis and Apoptosis. | Biomolecules | 2026 | https://conductscience.org/library/papers/41897283 | PubMed |
| 41596524 | Molecular and Immune Mechanisms Governing Cancer Metastasis, Including Dormancy, Microenvironmental Niches, and Tumor-Specific Programs. | Int J Mol Sci | 2026 | https://conductscience.org/library/papers/41596524 | PubMed |
| 41515615 | Primary Hepatic Squamous Cell Carcinoma. | Diagnostics (Basel) | 2026 | https://conductscience.org/library/papers/41515615 | PubMed |
| 41477347 | How histone modifications influence cellular radiosensitivity: Pharmaceutically targeting epigenetic regulators as a promising avenue to overcome radioresistance. | Acta Pharm Sin B | 2025 | https://conductscience.org/library/papers/41477347 | PubMed |
| 40661662 | Matrix Stiffness Regulates TGFβ1-Induced αSMA Expression via a G9a-LATS-YAP Signaling Cascade. | FASEB Bioadv | 2025 | https://conductscience.org/library/papers/40661662 | PubMed |
| 39991574 | Molecular insight into histone methylation as a novel target for oral squamous cell carcinoma: future hope in personalised medicine. | J Cancer | 2025 | https://conductscience.org/library/papers/39991574 | PubMed |
| 39574168 | Advances in the study of posttranslational modifications of histones in head and neck squamous cell carcinoma. | Clin Epigenetics | 2024 | https://conductscience.org/library/papers/39574168 | PubMed |
| 39272905 | Advancements in TGF-β Targeting Therapies for Head and Neck Squamous Cell Carcinoma. | Cancers (Basel) | 2024 | https://conductscience.org/library/papers/39272905 | PubMed |
| 38927881 | G9a in Cancer: Mechanisms, Therapeutic Advancements, and Clinical Implications. | Cancers (Basel) | 2024 | https://conductscience.org/library/papers/38927881 | PubMed |
| 38573544 | EHMT2 Suppresses ARRB1 Transcription and Activates the Hedgehog Signaling to Promote Malignant Phenotype and Stem Cell Property in Oral Squamous Cell Carcinoma. | Mol Biotechnol | 2025 | https://conductscience.org/library/papers/38573544 | PubMed |
| 37917782 | Uncovering key molecular mechanisms in the early and late-stage of papillary thyroid carcinoma using association rule mining algorithm. | PLoS One | 2023 | https://conductscience.org/library/papers/37917782 | PubMed |
| 37854925 | Epithelial-mesenchymal transition in cancer stem cells: Therapeutic implications. | J Oral Maxillofac Pathol | 2023 | https://conductscience.org/library/papers/37854925 | PubMed |
| 37818051 | Cancer stem cells of head and neck squamous cell carcinoma; distance towards clinical application; a systematic review of literature. | Am J Cancer Res | 2023 | https://conductscience.org/library/papers/37818051 | PubMed |
| 37415839 | Comprehensive analysis of suppressor of cytokine signaling 2 protein in the malignant transformation of NSCLC. | Exp Ther Med | 2023 | https://conductscience.org/library/papers/37415839 | PubMed |
| 37394580 | Histone modifications in drug-resistant cancers: From a cancer stem cell and immune evasion perspective. | Exp Mol Med | 2023 | https://conductscience.org/library/papers/37394580 | PubMed |
| 37344626 | Epigenetic regulation of hybrid epithelial-mesenchymal cell states in cancer. | Oncogene | 2023 | https://conductscience.org/library/papers/37344626 | PubMed |
| 36896891 | Histone-lysine N-methyltransferase EHMT2 (G9a) inhibition mitigates tumorigenicity in Myc-driven liver cancer. | Mol Oncol | 2023 | https://conductscience.org/library/papers/36896891 | PubMed |
| 35740522 | Potential Therapeutics Targeting Upstream Regulators and Interactors of EHMT1/2. | Cancers (Basel) | 2022 | https://conductscience.org/library/papers/35740522 | PubMed |
Genes32
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/25749385
GET https://conductscience.org/api/papers/v1/25749385/references?page=2